Insomnia

We conducted a 30-day study with adults who self-reported sleep difficulties and after using Modius Sleep we found that:

95% of participants improved their overall Sleep Score;

85% were more satisfied with their sleep pattern;

75% reported positive impact on their daily functioning.

A statistically significant reduction in mean Insomnia Severity Index (ISI) score from 15.7 (moderate insomnia) at baseline to 8.15 (sub-threshold insomnia) after 14 days of CES treatment was observed. ISI score reduced by 7.55 (i.e., 48% reduction).

* BMJ Journals: Mckeown J, Goothy SSK, P050 Modulation of sleep using electrical vestibular nerve stimulation prior to sleep onset.

Severe Sleep Disturbance Mild Sleep Disturbance Normal (2 weeks) With Modius SLEEP Before

Anxiety

A study in vistibular neurostimulation generated a HAM-A score reduced by 17.46 (i.e., 71% reduction).

A statistically significant reduction in mean Hamilton Anxiety Rating Scale (HAM-A) score from 24.55 (mild to moderate anxiety) at baseline to 7.09 (mild anxiety) after up to 42 days of treatment.

Type 2 Diabetes

In a 16-week study with type 2 diabetic patients, our Vestal DM technology demonstrated a 0.4% reduction in HbA1c.

We are further investigating the impact of our technology on type 2 diabetes in a 6-month global clinical trial. Data will be made available upon the completion of this trial.

Obesity

In a 12-week study with overweight patients, our Vestal technology demonstrated a 2.1kg reduction in body weight (i.e., 2% reduction in body weight).

We are further investigating the impact of our technology on obesity in a 6-month global clinical trial. Data will be made available upon the completion of this trial.

Clincial Trials | Neurovalens

Current Clinical Trials

Adults with Type 2 Diabetes

Electrical vestibular nerve stimulation (VeNS) compared to sham control as a means of improving glycemic control in adults with Type 2 Diabetes mellitus

Primary Outcomes: HbA1c reduction

Location: University College Dublin, Ireland

Dates: 2021 – 2023

Apply Now

Primary Outcomes: HbA1c reduction

Location: Nothern California Medical Research Centre

Dates: 2021 – 2023

Apply Now

Primary Outcomes: HbA1c reduction

Location: Oviedo Medical Research, Orlando Florida

Dates: 2021 – 2023

Apply Now

Primary Outcomes: HbA1c reduction

Location: Charlottesville Medical Research, Virginia

Dates: 2021 – 2023

Apply Now

Primary Outcomes: HbA1c reduction

Locations: The Exercise and Physical Activity Resource Center (EPARC), San Diego

Dates: 2021 – 2023

Apply Now

Type 2 Diabetes Weight Loss

Weight management study for individuals with Type 2 Diabetes taking insulin

Primary Outcomes: Weight loss & reduced HbA1c

Locations: Belfast, Northern Ireland

Dates: 2022

Apply Now

Anxiety

Electrical vestibular nerve stimulation (VeNS) as a management device for anxiety

Primary Outcomes: Reduced stress & anxiety

Locations: Belfast, Northern Ireland

Dates: 2022

Apply Now

Insomnia

Electrical vestibular nerve stimulation (VeNS) as a management device for insomnia

Primary Outcomes: Improved sleep & fatigue

Locations: Ulster University, Coleraine, Northern Ireland

Dates: 2022

Apply Now

Clinical Papers

Modulation of sleep using electrical vestibular nerve stimulation prior to sleep onset View Clincial Paper
Electrical vestibular nerve stimulation (VeNS) View Clincial Paper
The efficacy of cranial electrotherapy stimulation (CES) for the relief of anxiety and depression among polysubstance abusers in chemical dependency treatment View Clincial Paper
Anti-diabetic effect of vestibular stimulation is mediated via AMP-activated T protein kinase View Clincial Paper
Electrical vestibular nerve stimulation as an adjunctive therapy in the management of type 2 diabetes View Clincial Paper
Investigation of effects of galvanic vestibular stimulationon patients With type 2 diabetes View Clincial Paper
Vestibular stimulation: A simple but effective intervention in diabetes care View Clincial Paper
Can vestibular stimulation be used to treat obesity? View Clincial Paper
Modulation of body mass composition using vestibular nerve stimulation View Clincial Paper
The influence of vestibular stimulation on metabolism and body composition View Clincial Paper
Cranial Electrotherapy Stimulation as a Treatment for Anxiety in Chemically Dependent Persons View Clincial Paper